A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)

被引：0

作者：

Masashi Kanai

Etsuro Hatano

Shogo Kobayashi

Yutaka Fujiwara

Shigeru Marubashi

Atsushi Miyamoto

Hisanori Shiomi

Shoji Kubo

Shinichi Ikuta

Hiroaki Yanagimoto

Hiroaki Terajima

Hisashi Ikoma

Daisuke Sakai

Yuzo Kodama

Satoru Seo

Satoshi Morita

Tetsuo Ajiki

Hiroaki Nagano

Tatsuya Ioka

机构：

[1] Kyoto University,Department of Clinical Oncology and Pharmacogenomics, Graduate School of Medicine

[2] Kyoto University,Department of Surgery, Graduate School of Medicine

[3] Osaka University,Department of Surgery, Graduate School of Medicine

[4] National Cancer Center Hospital,Department of Experimental Therapeutics, Exploratory Oncology Research and Clinical Trial Center

[5] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Surgery

[6] National Hospital Organization Osaka National Hospital,Department of Surgery

[7] Shiga University of Medical Science,Department of Surgery

[8] Osaka City University Graduate School of Medicine,Department of Hepato

[9] Meiwa General Hospital,Biliary

[10] Kansai Medical University,Pancreatic Surgery

[11] Kitano Hospital,Department of Surgery

[12] Kyoto Prefectural University of Medicine,Department of Surgery

[13] Osaka University,Department of Gastroenterological Surgery and Oncology

[14] Kyoto University Hospital,Division of Digestive Surgery, Department of Surgery

[15] Kyoto University Graduate School of Medicine,Department of Frontier Science for Cancer and Chemotherapy, Graduate School of Medicine

[16] Kobe University Hospital,Department of Gastroenterology and Hepatology, Graduate School of Medicine

[17] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Biomedical Statistics and Bioinformatics

来源：

Cancer Chemotherapy and Pharmacology | 2015年 / 75卷

关键词：

Biliary; Gemcitabine; Cisplatin; S-1; Chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：293 / 300

页数：7

共 50 条

[1] A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)
Kanai, Masashi
Hatano, Etsuro
Kobayashi, Shogo
Fujiwara, Yutaka
Marubashi, Shigeru
Miyamoto, Atsushi
Shiomi, Hisanori
Kubo, Shoji
Ikuta, Shinichi
Yanagimoto, Hiroaki
Terajima, Hiroaki
Ikoma, Hisashi
Sakai, Daisuke
Kodama, Yuzo
Seo, Satoru
Morita, Satoshi
Ajiki, Tetsuo
Nagano, Hiroaki
Ioka, Tatsuya
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 293 - 300
[2] A MULTI-INSTITUTION PHASE II STUDY OF GEMCITABINE/CISPLATIN/S-1 (GCS) COMBINATION CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCER (KHBO 1002)
Kobayashi, S.
Kanai, M.
Hatano, E.
Fujiwara, Y.
Marubashi, S.
Miyamoto, A.
Shiomi, H.
Kubo, S.
Ikuta, S.
Yanagimoto, H.
Terajima, H.
Ikoma, H.
Sakai, D.
Kodama, Y.
Seo, S.
Morita, S.
Ajiki, T.
Nagano, H.
Ioka, T.
JOURNAL OF HEPATOLOGY, 2015, 62 : S451 - S451
[3] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
Kanai, Masashi
Yoshimura, Kenichi
Tsumura, Takehiko
Asada, Masanori
Suzuki, Chihiro
Niimi, Miyuki
Matsumoto, Shigemi
Nishimura, Takafumi
Nitta, Takashi
Yasuchika, Kentaro
Taura, Kojiro
Mori, Yukiko
Hamada, Akihiko
Inoue, Naoya
Tada, Shinsuke
Yanagihara, Kazuhiro
Yazumi, Shujiro
Osaki, Yukio
Chiba, Tsutomu
Ikai, Iwao
Fukushima, Masanori
Uemoto, Shinji
Hatano, Etsuro
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1429 - 1434
[4] A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
Masashi Kanai
Kenichi Yoshimura
Takehiko Tsumura
Masanori Asada
Chihiro Suzuki
Miyuki Niimi
Shigemi Matsumoto
Takafumi Nishimura
Takashi Nitta
Kentaro Yasuchika
Kojiro Taura
Yukiko Mori
Akihiko Hamada
Naoya Inoue
Shinsuke Tada
Kazuhiro Yanagihara
Shujiro Yazumi
Yukio Osaki
Tsutomu Chiba
Iwao Ikai
Masanori Fukushima
Shinji Uemoto
Etsuro Hatano
Cancer Chemotherapy and Pharmacology, 2011, 67 : 1429 - 1434
[5] Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
Kobayashi, Shogo
Kanai, Masashi
Hatano, Etsuro
Fujiwara, Yutaka
Sakai, Daisuke
Kodama, Yuzo
Ajiki, Tetsuo
Nagano, Hiroaki
Ioka, Tatsuya
HEPATOLOGY, 2012, 56 : 470A - 471A
[6] Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
Kanai, Masashi
Hatano, Etsuro
Kobayashi, Syogo
Fujiwara, Yutaka
Sakai, Daisuke
Kodama, Yuzo
Ajiki, Tetsuo
Nagano, Hiroaki
Ioka, Tatsuya
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1181 - 1188
[7] Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002)
Masashi Kanai
Etsuro Hatano
Syogo Kobayashi
Yutaka Fujiwara
Daisuke Sakai
Yuzo Kodama
Tetsuo Ajiki
Hiroaki Nagano
Tatsuya Ioka
Cancer Chemotherapy and Pharmacology, 2012, 69 : 1181 - 1188
[8] Phase Ⅰ trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
Akinori Watanabe
Mitsuhiro Kida
Shiro Miyazawa
Tomohisa Iwai
Kosuke Okuwaki
Toru Kaneko
Hiroshi Yamauchi
Miyoko Takezawa
Hiroshi Imaizumi
Wasaburo Koizumi
World Journal of Gastroenterology, 2015, (19) : 5979 - 5984
[9] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Takashi Sasaki
Hiroyuki Isayama
Yousuke Nakai
Yukiko Ito
Hirofumi Kogure
Osamu Togawa
Nobuo Toda
Ichiro Yasuda
Osamu Hasebe
Iruru Maetani
Naoki Sasahira
Kenji Hirano
Takeshi Tsujino
Minoru Tada
Masao Omata
Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
[10] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Sasaki, Takashi
Isayama, Hiroyuki
Nakai, Yousuke
Ito, Yukiko
Kogure, Hirofumi
Togawa, Osamu
Toda, Nobuo
Yasuda, Ichiro
Hasebe, Osamu
Maetani, Iruru
Sasahira, Naoki
Hirano, Kenji
Tsujino, Takeshi
Tada, Minoru
Omata, Masao
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107

← 1 2 3 4 5 →